Table I.
General clinical characteristics of the 104 patients.
| Variables | Value |
|---|---|
| Age (years) | |
| ≤65 | 53 (51.0) |
| >65 | 51 (49.0) |
| Sex | |
| Male | 88 (84.6) |
| Female | 16 (15.4) |
| Pathological type | |
| SCC | 99 (95.2) |
| Others | 5 (4.8) |
| Location | |
| Upper | 29 (27.9) |
| Middle | 52 (50.0) |
| Lower | 23 (22.1) |
| Length (cm) | |
| ≤5 | 46 (44.2) |
| >5–7 | 26 (25.0) |
| >7 | 32 (30.8) |
| T-classification | |
| T1-2 | 14 (13.5) |
| T3-4 | 90 (86.5) |
| N-classification | |
| N0 | 36 (34.6) |
| N1 | 63 (60.6) |
| N2 | 5 (4.8) |
| Clinic stage | |
| I | 5 (4.8) |
| II | 21 (20.2) |
| III | 78 (75.0) |
| Radiotherapy dose (Gy) | |
| 60 | 51 (49.0) |
| 66 | 53 (51.0) |
| Therapeutic method | |
| Radiotherapy alone | 53 (51.0) |
| Concurrent chemoradiation | 41 (39.4) |
| Sequential chemoradiation | 10 (9.6) |
| Neutrophil count (×109/ml) | 4.73±1.89 |
| Lymphocyte count (×109/ml) | 2.00±0.71 |
| Platelet count (×109/ml) | 244.58±78.27 |
| Monocyte count (×109/ml) | 0.51±0.25 |
| NLR | 2.64±1.34 |
| PLR | 138.87±64.69 |
| LMR | 4.62±2.30 |
All values are presented as the number of patients (with %), except for neutrophil, lymphocyte, platelet and monocyte counts, and NLR, PLR and LMR, which are presented as the mean ± standard deviation. SCC, squamous cell carcinoma; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-leukocyte ratio; LMR, lymphocyte-to-monocyte ratio.